744 related articles for article (PubMed ID: 27780585)
21. Role of the purinergic signaling in epilepsy.
Cieślak M; Wojtczak A; Komoszyński M
Pharmacol Rep; 2017 Feb; 69(1):130-138. PubMed ID: 27915186
[TBL] [Abstract][Full Text] [Related]
22. Osteoblast responses to nucleotides increase during differentiation.
Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
[TBL] [Abstract][Full Text] [Related]
23. Purinergic regulation of epithelial transport.
Bucheimer RE; Linden J
J Physiol; 2004 Mar; 555(Pt 2):311-21. PubMed ID: 14694149
[TBL] [Abstract][Full Text] [Related]
24. Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1.
Trueblood KE; Mohr S; Dubyak GR
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1213-23. PubMed ID: 21832250
[TBL] [Abstract][Full Text] [Related]
25. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
Neary JT; McCarthy M; Kang Y; Zuniga S
Neurosci Lett; 1998 Feb; 242(3):159-62. PubMed ID: 9530930
[TBL] [Abstract][Full Text] [Related]
26. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
Jacobson KA; IJzerman AP; Müller CE
Biochem Pharmacol; 2021 May; 187():114311. PubMed ID: 33130128
[TBL] [Abstract][Full Text] [Related]
27. Purinergic transmission in blood vessels.
Ralevic V; Dunn WR
Auton Neurosci; 2015 Sep; 191():48-66. PubMed ID: 26004513
[TBL] [Abstract][Full Text] [Related]
28. Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.
Lu D; Insel PA
Am J Physiol Cell Physiol; 2014 May; 306(9):C779-88. PubMed ID: 24352335
[TBL] [Abstract][Full Text] [Related]
29. ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI.
Rabadi M; Kim M; Li H; Han SJ; Choi Y; D'Agati V; Lee HT
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F293-F305. PubMed ID: 29021225
[TBL] [Abstract][Full Text] [Related]
30. Purinergic signaling in the inner ear.
Lee JH; Marcus DC
Hear Res; 2008 Jan; 235(1-2):1-7. PubMed ID: 17980525
[TBL] [Abstract][Full Text] [Related]
31. Complementary Role of P2 and Adenosine Receptors in ATP Induced-Anti-Apoptotic Effects Against Hypoxic Injury of HUVECs.
Feliu C; Peyret H; Poitevin G; Cazaubon Y; Oszust F; Nguyen P; Millart H; Djerada Z
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909368
[TBL] [Abstract][Full Text] [Related]
32. Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts.
Korcok J; Raimundo LN; Ke HZ; Sims SM; Dixon SJ
J Bone Miner Res; 2004 Apr; 19(4):642-51. PubMed ID: 15005852
[TBL] [Abstract][Full Text] [Related]
33. Extracellular nucleotide regulation and signaling in cardiac fibrosis.
Novitskaya T; Chepurko E; Covarrubias R; Novitskiy S; Ryzhov SV; Feoktistov I; Gumina RJ
J Mol Cell Cardiol; 2016 Apr; 93():47-56. PubMed ID: 26891859
[TBL] [Abstract][Full Text] [Related]
34. Purine and pyrimidine receptors.
Burnstock G
Cell Mol Life Sci; 2007 Jun; 64(12):1471-83. PubMed ID: 17375261
[TBL] [Abstract][Full Text] [Related]
35. Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?
Merighi S; Poloni TE; Terrazzan A; Moretti E; Gessi S; Ferrari D
Cells; 2021 May; 10(5):. PubMed ID: 34065393
[TBL] [Abstract][Full Text] [Related]
36. Extracellular nucleotide and nucleoside signaling in vascular and blood disease.
Idzko M; Ferrari D; Riegel AK; Eltzschig HK
Blood; 2014 Aug; 124(7):1029-37. PubMed ID: 25001468
[TBL] [Abstract][Full Text] [Related]
37. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
38. Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-alpha release in lipopolysaccharide-stimulated astrocytes.
Kucher BM; Neary JT
J Neurochem; 2005 Feb; 92(3):525-35. PubMed ID: 15659223
[TBL] [Abstract][Full Text] [Related]
39. A Purinergic Trail for Metastases.
Ferrari D; Malavasi F; Antonioli L
Trends Pharmacol Sci; 2017 Mar; 38(3):277-290. PubMed ID: 27989503
[TBL] [Abstract][Full Text] [Related]
40. The dark side of extracellular ATP in kidney diseases.
Solini A; Usuelli V; Fiorina P
J Am Soc Nephrol; 2015 May; 26(5):1007-16. PubMed ID: 25452669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
